Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 696

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1C
Chunk 696
---

     125,555 
  
    (Principal Executive Officer) 
     2022  
     54,510  
     -  
     -  
     -  
     54,510 
  
    Tyrone Miller 
     2024  
    $204,000  
    $20,000  
    $19,525  
    $41,000  
    $284,525 
  
    Chief Financial Officer 
     2023  
     135,632  
     -  
     -  
     -  
     135,632 
  
    (Principal Financial and Accounting Officer) 
     2022  
     148,672  
     -  
     -  
     -  
     148,672 
  
    Kristen Landon 
     2024  
    $300,000  
    $113,570  
    $38,125  
    $19,167  
    $470,862 
  
    Chief Commercial Officer 
     2023  
     -  
     -  
     -  
     -  
     - 

     2022  
     -  
     -  
     -  
     -  
     - 

    (1)
    We periodically review, and may increase, base salaries in accordance
    with our normal annual compensation review for each of our named executive officers.

Equity Awards

On July 12, 2023, Dr. Dow was granted a five-year
option to purchase a total of 250 shares of our common stock on the last day of each quarter in each calendar year (for a cumulative
total or no more than 5,000 shares over five years) and (ii) Mr. Miller was granted a five-year option to purchase a total of 200 shares
of our common stock on the last day of each quarter in each calendar year (for a cumulative total or no more than 4,000 shares over five
years). The per share exercise price of the options were initially equal to the per share closing price of our common stock on the date
of grant and had a cashless exercise provision. In November 2023, the Board reset the exercise price of the options to be equal to $60.00
and modified the vesting provisions